Ampio Pharmaceuticals, Inc. (AMPE) Financials
AMPE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 7.6 million | 2.3 million |
| 2023-06-30 | 9.1 million | 2.6 million |
| 2023-03-31 | 10.7 million | 2.9 million |
| 2022-12-31 | 13.6 million | 1.8 million |
AMPE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -555000 | 44000 |
| 2023-06-30 | -3.4 million | 53000 |
| 2023-03-31 | -2.3 million | 23000 |
| 2022-12-31 | -4.3 million | 160000 |
AMPE Net Income
No data available :(
AMPE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 6.4 million | - | 362000 |
| 2023-06-30 | 7.0 million | - | 448000 |
| 2023-03-31 | 10.4 million | - | 532000 |
| 2022-12-31 | 12.7 million | - | 614000 |
AMPE Shares Outstanding
AMPE Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 329000 | 1.1 million | - |
| 2023-06-30 | - | 344000 | 1.2 million | - |
| 2023-03-31 | - | 524000 | 3.8 million | - |
| 2022-12-31 | - | 739000 | 2.0 million | - |
AMPE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | - |
| 2023-06-30 | - | - |
| 2023-03-31 | - | 245000 |
| 2022-12-31 | - | 369000 |
AMPE
Price: $0.26
52 week price:
Earnings Per Share: -11.70 USD
P/E Ratio: -0.15
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 49694
Market Capitalization: 1.0 million